A review of the neuro- and systemic inflammatory responses in post concussion symptoms: Introduction of the "post-inflammatory brain syndrome" PIBS

Brain, Behavior, and Immunity

Volumn 46, Issue , 2015, Pages 1-16

  Rathbone, Alasdair Timothy Llewelyn ^a   Tharmaradinam, Surejini ^b   Jiang, Shucui ^c   Rathbone, Michel P ^c   Kumbhare, Dinesh A ^d  

^a WESTERN UNIVERSITY   (Canada)

^b MCMASTER CHILDREN S HOSPITAL   (Canada)

^c MCMASTER UNIVERSITY   (Canada)

^d UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Brain concussion; Brain injuries; Inflammation; Post concussion syndrome

Indexed keywords

ANXIETY; APATHY; COGNITIVE DEFECT; CONCENTRATION LOSS; CONCUSSION; DEPRESSION; DIZZINESS; DSM-IV; EMOTIONAL DISORDER; EMOTIONAL STRESS; EXCITEMENT; FATIGUE; HEADACHE; HUMAN; ICD-10; IMMUNE RESPONSE; INFLAMMATION; IRRITABILITY; MEMORY DISORDER; NERVOUS SYSTEM INFLAMMATION; NEUROLOGIC DISEASE; NONHUMAN; NONREM SLEEP; PERSONALITY DISORDER; POST INFLAMMATORY BRAIN SYNDROME; POSTCONCUSSION SYNDROME; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; REVIEW; SLEEP DISORDER; STRESS; SYSTEMIC INFLAMMATION; TRAUMATIC BRAIN INJURY; BRAIN; BRAIN CONCUSSION; PATHOPHYSIOLOGY; POST-CONCUSSION SYNDROME; PSYCHOLOGY;

BRAIN; BRAIN CONCUSSION; HUMANS; INFLAMMATION; POST-CONCUSSION SYNDROME;

EID: 84928823774     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2015.02.009     Document Type: Review

References (237)

1. Abad V.C., Sarinas P.S.A., Guilleminault C. Sleep and rheumatologic disorders. Sleep Med. Rev. 2008, 12(3):211-228. 10.1016/j.smrv.2007.09.001.
2. Ali T., Orr W.C. Sleep disturbances and inflammatory bowel disease. Inflamm. Bowel Dis. 2014, 1. 10.1097/MIB.0000000000000108.
3. Almeida-Suhett C.P., Li Z., Marini A.M., Braga M.F.M., Eiden L.E. Temporal course of changes in gene expression suggests a cytokine-related mechanism for long-term hippocampal alteration after controlled cortical impact. J. Neurotrauma 2014, 31(7):683-690. 10.1089/neu.2013.3029.
4. Alt J.A., Sautter N.B., Mace J.C., Detwiller K.Y., Smith T.L. Antisomnogenic cytokines, quality of life, and chronic rhinosinusitis: a pilot study. The Laryngoscope 2014, 124(4):E107-14. 10.1002/lary.24412.
5. American Psychiatric Association. Task Force on DSM-IV. (2000). Diagnostic and Statistical Manual of Mental Disorders: DSM-IV-TR, fourth ed. Washington, D.C.
6. American Psychiatric Association.Task Force on DSM-IV Diagnostic and Statistical Manual of Mental Disorders 2013, American Psychiatric Association, Arlington, VA, Retrieved from dsm.psychiatryonline.org. fifth ed.
7. Anders S., Tanaka M., Kinney D.K. Depression as an evolutionary strategy for defense against infection. Brain Behav. Immun. 2013, 31:9-22. 10.1016/j.bbi.2012.12.002.
8. Anderson R.E., Hansson L.O., Nilsson O., Dijlai-Merzoug R., Settergren G. High serum S100B levels for trauma patients without head injuries. Neurosurgery 2001, 48(6):1255-1258. discussion 1258-60.
9. Anderson G., Maes M., Berk M. Biological underpinnings of the commonalities in depression, somatization, and chronic fatigue syndrome. Med. Hypotheses 2012, 78(6):752-756. 10.1016/j.mehy.2012.02.023.
10. Ashina M., Hansen J.M., Olesen J. Pearls and pitfalls in human pharmacological models of migraine: 30 years' experience. Cephalalgia 2013, 33(8):540-553. 10.1177/0333102412475234.
11. Athilingam P., Moynihan J., Chen L., D'Aoust R., Groer M., Kip K. Elevated levels of interleukin 6 and C-reactive protein associated with cognitive impairment in heart failure. Congest. Heart Fail. 2013, 19(2):92-98. 10.1111/chf.12007.
12. Baracchi F., Ingiosi A.M., Raymond R.M., Opp M.R. Sepsis-induced alterations in sleep of rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2011, 301(5):R1467-78. 10.1152/ajpregu.00354.2011.
13. Baratz R., Tweedie D., Rubovitch V., Luo W., Yoon J.S., Hoffer B.J., et al. Tumor necrosis factor-α synthesis inhibitor, 3,6'-dithiothalidomide, reverses behavioral impairments induced by minimal traumatic brain injury in mice. J. Neurochem. 2011, 118(6):1032-1042. 10.1111/j.1471-4159.2011.07377.x.
14. Barsevick A., Frost M., Zwinderman A., Hall P., Halyard M., GENEQOL Consortium I'm so tired: biological and genetic mechanisms of cancer-related fatigue. Qual. Life Res. 2010, 19(10):1419-1427. 10.1007/s11136-010-9757-7.
15. Bastian D., Tamburstuen M.V., Lyngstadaas S.P., Reikerås O. Systemic and local cytokine kinetics after total hip replacement surgery. Eur. Surg. Res. 2008, 41(4):334-340. 10.1159/000157176.
16. Bauer I.E., Pascoe M.C., Wollenhaupt-Aguiar B., Kapczinski F., Soares J.C. Inflammatory mediators of cognitive impairment in bipolar disorder. J. Psychiatr. Res. 2014, 56C:18-27. 10.1016/j.jpsychires.2014.04.017.
17. Bazarian J.J., Wong T., Harris M., Leahey N., Mookerjee S., Dombovy M. Epidemiology and predictors of post-concussive syndrome after minor head injury in an emergency population. Brain Inj. 1999, 13(3):173-189.
18. Bazarian J.J., Zemlan F.P., Mookerjee S., Stigbrand T. Serum S-100B and cleaved-tau are poor predictors of long-term outcome after mild traumatic brain injury. Brain Inj. 2006, 20(7):759-765. 10.1080/02699050500488207.
19. Begaz T., Kyriacou D.N., Segal J., Bazarian J.J. Serum biochemical markers for post-concussion syndrome in patients with mild traumatic brain injury. J. Neurotrauma 2006, 23(8):1201-1210. 10.1089/neu.2006.23.1201.
20. Bermpohl D., You Z., Lo E.H., Kim H.-H., Whalen M.J. TNF alpha and Fas mediate tissue damage and functional outcome after traumatic brain injury in mice. J. Cereb. Blood Flow Metab. 2007, 27(11):1806-1818. 10.1038/sj.jcbfm.9600487.
21. Bezemer G., Van Gool A.R., Fekkes D., Vrolijk J.M., Hansen B.E., Janssen H.L.A., de Knegt R.J. Psychiatric side effects and fluctuations in serotonergic parameters in the treatment of chronic hepatitis C infection. Neuropsychobiology 2012, 65(3):126-132. 10.1159/000330585.
22. Bhatt S., Zalcman S., Hassanain M., Siegel A. Cytokine modulation of defensive rage behavior in the cat: role of GABAA and interleukin-2 receptors in the medial hypothalamus. Neuroscience 2005, 133(1):17-28. 10.1016/j.neuroscience.2005.01.065.
23. Bhatt S., Bhatt R.S., Zalcman S.S., Siegel A. Peripheral and central mediators of lipopolysaccharide induced suppression of defensive rage behavior in the cat. Neuroscience 2009, 163(4):1002-1011. 10.1016/j.neuroscience.2009.07.050.
24. Bilgic A., Akgul A., Sezer S., Arat Z., Ozdemir F.N., Haberal M. Nutritional status and depression, sleep disorder, and quality of life in hemodialysis patients. J. Ren. Nutr. 2007, 17(6):381-388. 10.1053/j.jrn.2007.08.008.
25. Blacklaws H., Veysey H., Skinner V., Reid R.S., Hawken G., Veysey M. Interferon treatment for chronic hepatitis C: a family impact study. Gastroenterol. Nurs. 2009, 32(6):377-383. 10.1097/SGA.0b013e3181c10759.
26. Blacklaws H., Gardner A., Usher K. Irritability: an underappreciated side effect of interferon treatment for chronic hepatitis C?. J. Clin. Nurs. 2011, 20(9-10):1215-1224. 10.1111/j.1365-2702.2010.03494.x.
27. Breese G.R., Knapp D.J., Overstreet D.H., Navarro M., Wills T.A., Angel R.A. Repeated lipopolysaccharide (LPS) or cytokine treatments sensitize ethanol withdrawal-induced anxiety-like behavior. Neuropsychopharmacology 2007, 33(4):867-876. 10.1038/sj.npp.1301468.
28. Briones T.L., Woods J., Rogozinska M. Decreased neuroinflammation and increased brain energy homeostasis following environmental enrichment after mild traumatic brain injury is associated with improvement in cognitive function. Acta Neuropathol. Commun. 2013, 1(1):57. 10.1186/2051-5960-1-57.
29. Byrnes K.R., Loane D.J., Stoica B.A., Zhang J., Faden A.I. Delayed mGluR5 activation limits neuroinflammation and neurodegeneration after traumatic brain injury. J. Neuroinflammation 2012, 9(1):43. 10.1186/1742-2094-9-43.
30. Carroll L.J., Cassidy J.D., Peloso P.M., Borg J., von H., Holm L., et al. Prognosis for mild traumatic brain injury: results of the WHO Collaborating Centre Task Force On Mild Traumatic Brain Injury. J. Rehabil. Med. 2004, (Suppl. 43):84-105.
31. Cassidy D.J., Cancelliere C., Carroll L.J., Côté P., Hincapié C.A., Holm L.W., et al. Systematic review of self-reported prognosis in adults after mild traumatic brain injury: results of the international collaboration on mild traumatic brain injury prognosis. Arch. Phys. Med. Rehabil. 2014, (Suppl. 95):S132-S151. 10.1016/j.apmr.2013.08.299.
32. Cernak I. The importance of systemic response in the pathobiology of blast-induced neurotrauma. Front. Neurol. 2010, 1:151. 10.3389/fneur.2010.00151.
33. Chauffier K., Salliot C., Berenbaum F., Sellam J. Effect of biotherapies on fatigue in rheumatoid arthritis: a systematic review of the literature and meta-analysis. Rheumatology 2012, 51(1):60-68. 10.1093/rheumatology/ker162.
34. Chen J., Buchanan J.B., Sparkman N.L., Godbout J.P., Freund G.G., Johnson R.W. Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain Behav. Immun. 2008, 22(3):301-311. 10.1016/j.bbi.2007.08.014.
35. Cheung Y.T., Lim S.R., Ho H.K., Chan A. Cytokines as mediators of chemotherapy-associated cognitive changes: current evidence, limitations and directions for future research. PLoS One 2013, 8(12):e81234. 10.1371/journal.pone.0081234.
36. Chiu Y.-L., Chuang Y.-F., Fang K.-C., Liu S.-K., Chen H.-Y., Yang J.-Y., et al. Higher systemic inflammation is associated with poorer sleep quality in stable haemodialysis patients. Nephrol. Dial. Transplant. 2009, 24(1):247-251. 10.1093/ndt/gfn439.
37. Choy E. Understanding the dynamics: pathways involved in the pathogenesis of rheumatoid arthritis. Rheumatology 2012, 51(Suppl. 5):v3-11. 10.1093/rheumatology/kes113.
38. Clausen F., Hånell A., Israelsson C., Hedin J., Ebendal T., Mir A.K., et al. Neutralization of interleukin-1β reduces cerebral edema and tissue loss and improves late cognitive outcome following traumatic brain injury in mice. Eur. J. Neurosci. 2011, 34(1):110-123. 10.1111/j.1460-9568.2011.07723.x.
39. Clevenger L., Schrepf A., Christensen D., DeGeest K., Bender D., Ahmed A., et al. Sleep disturbance, cytokines, and fatigue in women with ovarian cancer. Brain Behav. Immun. 2012, 26(7):1037-1044. 10.1016/j.bbi.2012.04.003.
40. Constant A., Castera L., Dantzer R., Couzigou P., de Ledinghen V., Demotes-Mainard J., Henry C. Mood alterations during interferon-alfa therapy in patients with chronic hepatitis C: evidence for an overlap between manic/hypomanic and depressive symptoms. J. Clin. Psychiatry 2005, 66(8):1050-1057.
41. Correia S., Cohen R., Gongvatana A., Ross S., Olchowski J., Devlin K., et al. Relationship of plasma cytokines and clinical biomarkers to memory performance in HIV. J. Neuroimmunol. 2013, 265(1-2):117-123. 10.1016/j.jneuroim.2013.09.005.
42. Cunningham C., Maclullich A.M.J. At the extreme end of the psychoneuroimmunological spectrum: delirium as a maladaptive sickness behaviour response. Brain Behav. Immun. 2013, 28 (C):1-13. 10.1016/j.bbi.2012.07.012.
43. Dan A.A., Crone C., Wise T.N., Martin L.M., Ramsey L., Magee S., et al. Anger experiences among hepatitis C patients: relationship to depressive symptoms and health-related quality of life. Psychosomatics 2007, 48(3):223-229. 10.1176/appi.psy.48.3.223.
44. Dean P.J.A., O'Neill D., Sterr A. Post-concussion syndrome: prevalence after mild traumatic brain injury in comparison with a sample without head injury. Brain Inj. 2012, 26(1):14-26. 10.3109/02699052.2011.635354.
45. Deodhar A., Braun J., Inman R.D., Mack M., Parasuraman S., Buchanan J., et al. Golimumab reduces sleep disturbance in patients with active ankylosing spondylitis: results from a randomized, placebo-controlled trial. Arthritis Care Res. 2010, 62(9):1266-1271. 10.1002/acr.20233.
46. Dinarello C.A. Proinflammatory cytokines. Chest 2000, 118(2):503-508.
47. D'Mello C., Swain M.G. Liver-brain inflammation axis. Am. J. Physiol. Gastrointest. Liver Physiol. 2011, 301(5):G749-61. 10.1152/ajpgi.00184.2011.
48. Dowlati Y., Herrmann N., Swardfager W., Liu H., Sham L., Reim E.K., Lanctôt K.L. A meta-analysis of cytokines in major depression. Biol. Psychiatry 2010, 67(5):446-457. 10.1016/j.biopsych.2009.09.033.
49. Durham P., Papapetropoulos S. Biomarkers associated with migraine and their potential role in migraine management. Headache 2013, 53(8):1262-1277. 10.1111/head.12174.
50. Eccles R. Understanding the symptoms of the common cold and influenza. Lancet. Infect. Dis 2005, 5(11):718-725. 10.1016/S1473-3099(05)70270-X.
51. Eckel B., Ohl F., Bogdanski R., Kochs E.F., Blobner M. Cognitive deficits after systemic induction of inducible nitric oxide synthase: a randomised trial in rats. Eur. J. Anaesthesiol. 2011, 28(9):655-663. 10.1097/EJA.0b013e3283497ce1.
52. Ekmark-Lewén S., Flygt J., Kiwanuka O., Meyerson B.J., Lewén A., Hillered L., Marklund N. Traumatic axonal injury in the mouse is accompanied by a dynamic inflammatory response, astroglial reactivity and complex behavioral changes. J. Neuroinflammation 2013, 10(1):44. 10.1186/1742-2094-10-44.
53. Elderkin-Thompson V., Irwin M.R., Hellemann G., Kumar A. Interleukin-6 and memory functions of encoding and recall in healthy and depressed elderly adults. Am. J. Geriatr. Psychiatry 2012, 20(9):753-763. 10.1097/JGP.0b013e31825d08d6.
54. Eraly S.A., Nievergelt C.M., Maihofer A.X., Barkauskas D.A., Biswas N., Agorastos A., et al. Assessment of plasma C-reactive protein as a biomarker of posttraumatic stress disorder risk. JAMA Psychiatry 2014, 71(4):423-431. 10.1001/jamapsychiatry.2013.4374.
55. Erten Y., Kokturk O., Yuksel A., Elbeg S., Ciftci T.U., Pasaoglu H., et al. Relationship between sleep complaints and proinflammatory cytokines in haemodialysis patients. Nephrology 2005, 10(4):330-335. 10.1111/j.1440-1797.2005.00418.x.
56. Eser Karlidag G., Karlidag T., Demirdag K., Keles E. The effects of pegylated interferon/lamivudine therapy on auditory functions in patients with chronic hepatitis B. Auris, Nasus, Larynx 2011, 38(3):312-318. 10.1016/j.anl.2010.10.007.
57. Evans L.M., Itri L.M., Campion M., Wyler-Plaut R., Krown S.E., Groopman J.E., et al. Interferon-alpha 2a in the treatment of acquired immunodeficiency syndrome-related Kaposi's sarcoma. J. Immunother. 1991, 10(1):39-50.
58. Farag N.H., Rashed H.-A., Hassan M., Darweesh A., Shehata M., Hassanein T., Mills P.J. Hepatitis C infection, cognition, and inflammation in an Egyptian sample. J. Med. Virol. 2011, 83(2):261-266. 10.1002/jmv.21879.
59. Felger J.C., Miller A.H. Cytokine effects on the basal ganglia and dopamine function: the subcortical source of inflammatory malaise. Front. Neuroendocrinol. 2012, 33(3):315-327. 10.1016/j.yfrne.2012.09.003.
60. Festi D., Sandri L., Mazzella G., Roda E., Sacco T., Staniscia T., et al. Safety of interferon beta treatment for chronic HCV hepatitis. World J. Gastroenterol. 2004, 10(1):12-16.
61. Fidalgo A.R., Cibelli M., White J.P.M., Nagy I., Maze M., Ma D. Systemic inflammation enhances surgery-induced cognitive dysfunction in mice. Neurosci. Lett. 2011, 498(1):63-66. 10.1016/j.neulet.2011.04.063.
62. Finnoff J.T., Jelsing E.J., Smith J. Biomarkers, genetics, and risk factors for concussion. PM and R 2011, 3(10 Suppl. 2):S452-9. 10.1016/j.pmrj.2011.07.014.
63. Fleischmann R., Stern R., Iqbal I. Anakinra: an inhibitor of IL-1 for the treatment of rheumatoid arthritis. Exp. Opin. Biol. Ther. 2004, 4(8):1333-1344. 10.1517/14712598.4.8.1333.
64. Fragiadaki K., Tektonidou M.G., Konsta M., Chrousos G.P., Sfikakis P.P. Sleep disturbances and interleukin 6 receptor inhibition in rheumatoid arthritis. J. Rheumatol. 2012, 39(1):60-62. 10.3899/jrheum.110617.
65. Fumaz C.R., Muñoz-Moreno J.A., Ballesteros A.L., Paredes R., Ferrer M.J., Salas A., et al. Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients. AIDS Care 2007, 19(1):138-145. 10.1080/09540120600645539.
66. Ganz P.A., Bower J.E., Kwan L., Castellon S.A., Silverman D.H.S., Geist C., et al. Does tumor necrosis factor-alpha (TNF-α) play a role in post-chemotherapy cerebral dysfunction?. Brain Behav. Immun. 2013, 30(Suppl):S99-108. 10.1016/j.bbi.2012.07.015.
67. Gareau M.G., Wine E., Rodrigues D.M., Cho J.H., Whary M.T., Philpott D.J., et al. Bacterial infection causes stress-induced memory dysfunction in mice. Gut 2011, 60(3):307-317. 10.1136/gut.2009.202515.
68. Giunta B., Somboonwit C., Nikolic W.V., Rrapo E., Tan J., Shapshak P., Fernandez F. Psychiatric implications of hepatitis-C infection. Crit. Rev. Neurobiol. 2007, 19(2-3):79-118.
69. Gong Q., Li L., Du M., Pettersson-Yeo W., Crossley N., Yang X., et al. Quantitative prediction of individual psychopathology in trauma survivors using resting-state fMRI. Neuropsychopharmacology 2013, 39(3):681-687. 10.1038/npp.2013.251.
70. Gouvier W.D., Uddo-Crane M., Brown L.M. Base rates of post-concussional symptoms. Arch. Clin. Neuropsychol. 1988, 3(3):273-278.
71. Gul A., Aoun N., Trayner E.M. Why do patients sleep on dialysis?. Semin. Dial. 2006, 19(2):152-157. 10.1111/j.1525-139X.2006.00142.x.
72. Gunstad J., Suhr J.A. Cognitive factors in Postconcussion Syndrome symptom report. Arch. Clin. Neuropsychol. 2004, 19(3):391-405. 10.1016/S0887-6177(03)00073-8.
73. Haas D.C. Chronic post-traumatic headaches classified and compared with natural headaches. Cephalalgia 1996, 16(7):486-493. Retrieved from http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=8933993&retmode=ref&cmd=prlinks.
74. Halbauer J.D., Ashford J.W., Zeitzer J.M., Adamson M.M., Lew H.L., Yesavage J.A. Neuropsychiatric diagnosis and management of chronic sequelae of war-related mild to moderate traumatic brain injury. J. Rehabil. Res. Dev. 2009, 46(6):757-796.
75. Hamed S.A., Selim Z.I., Elattar A.M., Elserogy Y.M., Ahmed E.A., Mohamed H.O. Assessment of biocorrelates for brain involvement in female patients with rheumatoid arthritis. Clin. Rheumatol. 2012, 31(1):123-132. 10.1007/s10067-011-1795-1.
76. Harrington M.E. Neurobiological studies of fatigue. Prog. Neurobiol. 2012, 99(2):93-105. 10.1016/j.pneurobio.2012.07.004.
77. Harrison N.A., Brydon L., Walker C., Gray M.A., Steptoe A., Dolan R.J., Critchley H.D. Neural origins of human sickness in interoceptive responses to inflammation. Biol. Psychiatry 2009, 66(5):415-422. 10.1016/j.biopsych.2009.03.007.
78. Harrison J.L., Rowe R.K., O'Hara B.F., Adelson P.D., Lifshitz J. Acute over-the-counter pharmacological intervention does not adversely affect behavioral outcome following diffuse traumatic brain injury in the mouse. Exp. Brain Res. 2014, 10.1007/s00221-014-3948-3.
79. Hassanain M., Zalcman S., Bhatt S., Siegel A. Interleukin-1 beta in the hypothalamus potentiates feline defensive rage: role of serotonin-2 receptors. Neuroscience 2003, 120(1):227-233.
80. Hennessy M.B., Fitch C., Jacobs S., Deak T., Schiml P.A. Behavioral effects of peripheral corticotropin-releasing factor during maternal separation may be mediated by proinflammatory activity. Psychoneuroendocrinology 2011, 36(7):996-1004. 10.1016/j.psyneuen.2010.12.011.
81. Hickman S.E., Kingery N.D., Ohsumi T.K., Borowsky M.L., Wang L.-C., Means T.K., Khoury El.J. The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci. 2013, 16(12):1896-1905. 10.1038/nn.3554.
82. Hilsabeck R.C., Anstead G.M., Webb A.L., Hoyumpa A., Ingmundson P., Holliday S., et al. Cognitive efficiency is associated with endogenous cytokine levels in patients with chronic hepatitis C. J. Neuroimmunol. 2010, 221(1-2):53-61. 10.1016/j.jneuroim.2010.01.017.
83. Hohjoh H., Nakayama T., Ohashi J., Miyagawa T., Tanaka H., Akaza T., et al. Significant association of a single nucleotide polymorphism in the tumor necrosis factor-alpha (TNF-alpha) gene promoter with human narcolepsy. Tissue Antigens 1999, 54(2):138-145.
84. Holmin S., Schalling M., Höjeberg B., Nordqvist A.C., Skeftruna A.K., Mathiesen T. Delayed cytokine expression in rat brain following experimental contusion. J. Neurosurg. 1997, 86(3):493-504. 10.3171/jns.1997.86.3.0493.
85. Hon K.L., Ching G.K., Ng P.C., Leung T.F. Exploring CCL18, eczema severity and atopy. Pediatr. Allergy Immunol. 2011, 22(7):704-707. 10.1111/j.1399-3038.2011.01174.x.
86. Hovens I.B., Schoemaker R.G., van der Zee E.A., Absalom A.R., Heineman E., van Leeuwen B.L. Postoperative cognitive dysfunction: involvement of neuroinflammation and neuronal functioning. Brain Behav. Immun. 2014, 38:202-210. 10.1016/j.bbi.2014.02.002.
87. Huang X., Wang F., Chen W., Li Z., Wang N., Chen Y., von Maltzan K. Dao-Tan decoction inhibits tumor necrosis factor-α-induced intercellular adhesion molecule-1 expression by blocking JNK and p38 signaling pathways in human umbilical vein endothelial cells. Pharm. Biol. 2012, 50(9):1111-1117. 10.3109/13880209.2012.658476.
88. Hudetz J.A., Gandhi S.D., Iqbal Z., Patterson K.M., Pagel P.S. Elevated postoperative inflammatory biomarkers are associated with short- and medium-term cognitive dysfunction after coronary artery surgery. J. Anesth. 2011, 25(1):1-9. 10.1007/s00540-010-1042-y.
89. Irwin M., Rinetti G., Redwine L., Motivala S., Dang J., Ehlers C. Nocturnal proinflammatory cytokine-associated sleep disturbances in abstinent African American alcoholics. Brain Behav. Immun. 2004, 18(4):349-360. 10.1016/j.bbi.2004.02.001.
90. Iverson G.L., Lange R.T., Wäljas M., Liimatainen S., Dastidar P., Hartikainen K.M., et al. Outcome from complicated versus uncomplicated mild traumatic brain injury. Rehabil. Res. Pract. 2012, 2012(3):1-7. 10.1155/2012/415740.
91. Iwashyna T.J., Ely E.W., Smith D.M., Langa K.M. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 2010, 304(16):1787-1794. 10.1001/jama.2010.1553.
92. Jeong H.-J., Hong S.-H., Park H.-J., Kweon D.-Y., Lee S.-W., Lee J.-D., et al. Yangkyuk-Sanhwa-Tang induces changes in serum cytokines and improves outcome in focal stroke patients. Vascul. Pharmacol. 2002, 39(1-2):63-68.
93. Ji M.-H., Yuan H.-M., Zhang G.-F., Li X.-M., Dong L., Li W.-Y., et al. Changes in plasma and cerebrospinal fluid biomarkers in aged patients with early postoperative cognitive dysfunction following total hip-replacement surgery. J. Anesth. 2013, 27(2):236-242. 10.1007/s00540-012-1506-3.
94. Jiang M., Qin P., Yang X. Comorbidity between depression and asthma via immune-inflammatory pathways: a meta-analysis. J. Affect. Disord. 2014, 166C:22-29. 10.1016/j.jad.2014.04.027.
95. Jones K.A., Thomsen C. The role of the innate immune system in psychiatric disorders. Mol. Cell. Neurosci. 2013, 53:52-62. 10.1016/j.mcn.2012.10.002.
96. Kabadi S.V., Stoica B.A., Loane D.J., Luo T., Faden A.I. CR8, a novel inhibitor of CDK, limits microglial activation, astrocytosis, neuronal loss, and neurologic dysfunction after experimental traumatic brain injury. J. Cereb. Blood Flow Metab. 2014, 34(3):502-513. 10.1038/jcbfm.2013.228.
97. Kao C.-L., Tsai K.-L., Cheng Y.-Y., Kuo C.-H., Lee S.-D., Chan R.-C. Vestibular rehabilitation ameliorates chronic dizziness through the SIRT1 axis. Front. Aging Neurosci. 2014, 6:27. 10.3389/fnagi.2014.00027.
98. Karadağ O., Nakas D., Kalyoncu U., Akdoğan A., Kiraz S., Ertenli I. Effect of anti-TNF treatment on sleep problems in ankylosing spondylitis. Rheumatol. Int. 2012, 32(7):1909-1913. 10.1007/s00296-011-1907-x.
99. Kelley K.W., Bluthé R.-M., Dantzer R., Zhou J.-H., Shen W.-H., Johnson R.W., Broussard S.R. Cytokine-induced sickness behavior. Brain Behav. Immun. 2003, 17(Suppl. 1):S112-8.
100. Kesler S., Janelsins M., Koovakkattu D., Palesh O., Mustian K., Morrow G., Dhabhar F.S. Reduced hippocampal volume and verbal memory performance associated with interleukin-6 and tumor necrosis factor-alpha levels in chemotherapy-treated breast cancer survivors. Brain Behav. Immun. 2013, 30(Suppl):S109-16. 10.1016/j.bbi.2012.05.017.
101. Khuman J., Meehan W.P., Zhu X., Qiu J., Hoffmann U., Zhang J., et al. Tumor necrosis factor alpha and Fas receptor contribute to cognitive deficits independent of cell death after concussive traumatic brain injury in mice. J. Cereb. Blood Flow Metab. 2011, 31(2):778-789. 10.1038/jcbfm.2010.172.
102. Kim B.-W., Koppula S., Kim J.-W., Lim H.-W., Hwang J.-W., Kim I.-S., et al. Modulation of LPS-stimulated neuroinflammation in BV-2 microglia by Gastrodia elata: 4-hydroxybenzyl alcohol is the bioactive candidate. J. Ethnopharmacol. 2012, 139(2):549-557. 10.1016/j.jep.2011.11.048.
103. Kinoshita K., Chatzipanteli I.K., Vitarbo E., Truettner J.S., Alonso O.F., Dietrich W.D. Interleukin-1beta messenger ribonucleic acid and protein levels after fluid-percussion brain injury in rats: importance of injury severity and brain temperature. Neurosurgery 2002, 51(1):195-203. discussion 203.
104. Kleindienst A., Ross Bullock M. A critical analysis of the role of the neurotrophic protein S100B in acute brain injury. J. Neurotrauma 2006, 23(8):1185-1200. 10.1089/neu.2006.23.1185.
105. Knapp D.J., Whitman B.A., Wills T.A., Angel R.A., Overstreet D.H., Criswell H.E., et al. Cytokine involvement in stress may depend on corticotrophin releasing factor to sensitize ethanol withdrawal anxiety. Brain Behav. Immun. 2011, 25(Suppl. 1):S146-54. 10.1016/j.bbi.2011.02.018.
106. Kranjac D., McLinden K.A., Deodati L.E., Papini M.R., Chumley M.J., Boehm G.W. Peripheral bacterial endotoxin administration triggers both memory consolidation and reconsolidation deficits in mice. Brain Behav. Immun. 2012, 26(1):109-121. 10.1016/j.bbi.2011.08.005.
107. Kraus M.R., Schäfer A., Faller H., Csef H., Scheurlen M. Paroxetine for the treatment of interferon-alpha-induced depression in chronic hepatitis C. Aliment. Pharmacol. Ther. 2002, 16(6):1091-1099.
108. Kraus M.-R., Schäfer A., Faller H., Csef H., Scheurlen M. Psychiatric symptoms in patients with chronic hepatitis C receiving interferon alfa-2b therapy. J. Clin. Psychiatry 2003, 64(6):708-714.
109. Kraus M.-R., Schäfer A., Csef H., Scheurlen M. Psychiatric side effects of pegylated interferon alfa-2b as compared to conventional interferon alfa-2b in patients with chronic hepatitis C. World J. Gastroenterol. 2005, 11(12):1769-1774.
110. Kronenberger B., Berg T., Herrmann E., Hinrichsen H., Gerlach T., Buggisch P., et al. Efficacy of amantadine on quality of life in patients with chronic hepatitis C treated with interferon-alpha and ribavirin: results from a randomized, placebo-controlled, double-blind trial. Eur. J. Gastroenterol. Hepatol. 2007, 19(8):639-646. 10.1097/MEG.0b013e3281ac20ca.
111. Krouse H.J., Davis J.E., Krouse J.H. Immune mediators in allergic rhinitis and sleep. Otolaryngol. Head Neck Surg. 2002, 126(6):607-613.
112. Kunz-Ebrecht S.R., Mohamed-Ali V., Feldman P.J., Kirschbaum C., Steptoe A. Cortisol responses to mild psychological stress are inversely associated with proinflammatory cytokines. Brain Behav. Immun. 2003, 17(5):373-383.
113. Lagarde E., Salmi L.-R., Holm L.W., Contrand B., Masson F., Ribéreau-Gayon R., et al. Association of symptoms following mild traumatic brain injury with posttraumatic stress disorder vs postconcussion syndrome. JAMA Psychiatry 2014, 10.1001/jamapsychiatry.2014.666.
114. Lee J.H., Kim S.J., Jung H.H. Nocturnal sleep related with metabolic markers in end-stage renal disease patients receiving hemodialysis. Psychiatry Invest. 2009, 6(1):34-38. 10.4306/pi.2009.6.1.34.
115. Lee K.A., Gay C., Pullinger C.R., Hennessy M.D., Zak R.S., Aouizerat B.E. Cytokine polymorphisms are associated with poor sleep maintenance in adults living with human immunodeficiency virus/acquired immunodeficiency syndrome. Sleep 2014, 37(3):453-463. 10.5665/sleep.3474.
116. Lenz A., Franklin G.A., Cheadle W.G. Systemic inflammation after trauma. Injury 2007, 38(12):1336-1345. 10.1016/j.injury.2007.10.003.
117. Leonard B., Maes M. Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression. Neurosci. Biobehav. Rev. 2012, 36(2):764-785. 10.1016/j.neubiorev.2011.12.005.
118. Levy D. Endogenous mechanisms underlying the activation and sensitization of meningeal nociceptors: the role of immuno-vascular interactions and cortical spreading depression. Curr. Pain Headache Rep. 2012, 16(3):270-277. 10.1007/s11916-012-0255-1.
119. Leys L.J., Chu K.L., Xu J., Pai M., Yang H.S., Robb H.M., et al. Disturbances in slow-wave sleep are induced by models of bilateral inflammation, neuropathic, and postoperative pain, but not osteoarthritic pain in rats. Pain 2013, 154(7):1092-1102. 10.1016/j.pain.2013.03.019.
120. Li J., Guo Q., Ye X., Lin J., Yi C., Mao H., et al. Prevalence and risk factors of sleep disturbance in continuous ambulatory peritoneal dialysis patients in Guangzhou, southern China. Int. Urol. Nephrol. 2012, 44(3):929-936. 10.1007/s11255-011-0060-5.
121. Liao Y., Liu P., Guo F., Zhang Z.-Y., Zhang Z. Oxidative burst of circulating neutrophils following traumatic brain injury in human. PLoS One 2013, 8(7):e68963. 10.1371/journal.pone.0068963.
122. Lin Y., Wen L. Inflammatory response following diffuse axonal injury. Int. J. Med. Sci. 2013, 10(5):515-521. 10.7150/ijms.5423.
123. Liu P., Li Y.-S., Quartermain D., Boutajangout A., Ji Y. Inhaled nitric oxide improves short term memory and reduces the inflammatory reaction in a mouse model of mild traumatic brain injury. Brain Res. 2013, 1522:67-75. 10.1016/j.brainres.2013.05.032.
124. Lloyd E., Somera-Molina K., Van Eldik L.J., Watterson D.M., Wainwright M.S. Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury. J. Neuroinflammation 2008, 5(1):28. 10.1186/1742-2094-5-28.
125. Lopresti A.L., Hood S.D., Drummond P.D. A review of lifestyle factors that contribute to important pathways associated with major depression: diet, sleep and exercise. J. Affect. Disord. 2013, 148(1):12-27. 10.1016/j.jad.2013.01.014.
126. Lorusso L., Mikhaylova S.V., Capelli E., Ferrari D., Ngonga G.K., Ricevuti G. Immunological aspects of chronic fatigue syndrome. Autoimmun. Rev. 2009, 8(4):287-291. 10.1016/j.autrev.2008.08.003.
127. Lotrich F.E., Ferrell R.E., Rabinovitz M., Pollock B.G. Labile anger during interferon alfa treatment is associated with a polymorphism in tumor necrosis factor alpha. Clin. Neuropharmacol. 2010, 33(4):191-197. 10.1097/WNF.0b013e3181de8966.
128. Lotrich F.E., Sears B., McNamara R.K. Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids. J. Psychosom. Res. 2013, 75(5):475-483. 10.1016/j.jpsychores.2013.07.012.
129. Lotrich F.E., Butters M.A., Aizenstein H., Marron M.M., Reynolds C.F., Gildengers A.G. The relationship between interleukin-1 receptor antagonist and cognitive function in older adults with bipolar disorder. Int. J. Geriatr. Psychiatry 2014, 29(6):635-644. 10.1002/gps.4048.
130. Lu C.-Y., Yi P.-L., Tsai C.-H., Cheng C.-H., Chang H.-H., Hsiao Y.-T., Chang F.-C. TNF-NF-kappaB signaling mediates excessive somnolence in hemiparkinsonian rats. Behav. Brain Res. 2010, 208(2):484-496. 10.1016/j.bbr.2009.12.028.
131. Maddock C., Baita A., Orrù M.G., Sitzia R., Costa A., Muntoni E., et al. Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms. J. Psychopharmacol. 2004, 18(1):41-46. 10.1177/0269881104040230.
132. Majde J.A., Krueger J.M. Links between the innate immune system and sleep. J. Allergy Clin. Immunol. 2005, 116(6):1188-1198. 10.1016/j.jaci.2005.08.005.
133. Markova E.V., Chernova T.G., Fillimonov P.N., Korotkova N.A., Abramov V.V., Kozlov V.A. Immunomorphological characteristics of animals with different levels of orientation and exploratory behavior. Bull. Exp. Biol. Med. 2004, 138(4):415-417.
134. Maruta J., Lee S.W., Jacobs E.F., Ghajar J. A unified science of concussion. Ann. NY Acad. Sci. 2010, 1208(1):58-66. 10.1111/j.1749-6632.2010.05695.x.
135. Mayer C.L., Huber B.R., Peskind E. Traumatic brain injury, neuroinflammation, and post-traumatic headaches. Headache 2013, 53(9):1523-1530. 10.1111/head.12173.
136. McAllister T.W., Arciniegas D. Evaluation and treatment of postconcussive symptoms. NeuroRehabilitation 2002, 17(4):265-283.
137. McCauley S.R., Boake C., Pedroza C., Brown S.A., Levin H.S., Goodman H.S., Merritt S.G. Postconcussional disorder: are the DSM-IV criteria an improvement over the ICD-10?. J. Nerv. Ment. Dis. 2005, 193(8):540-550.
138. McCusker R.H., Kelley K.W. Immune-neural connections: how the immune system's response to infectious agents influences behavior. J. Exp. Biol. 2012, 216(1):84-98. 10.1242/jeb.073411.
139. Meares S., Shores E.A., Batchelor J., Baguley I.J., Chapman J., Gurka J., Marosszeky J.E. The relationship of psychological and cognitive factors and opioids in the development of the postconcussion syndrome in general trauma patients with mild traumatic brain injury. J. Int. Neuropsychol. Soc. 2006, 12(6):792-801. 10.1017/S1355617706060978.
140. Meares S., Shores E.A., Taylor A.J., Batchelor J., Bryant R.A., Baguley I.J., et al. Mild traumatic brain injury does not predict acute postconcussion syndrome. J. Neurol. Neurosurg. Psychiatry 2008, 79(3):300-306. 10.1136/jnnp.2007.126565.
141. Meares S., Shores E.A., Taylor A.J., Batchelor J., Bryant R.A., Baguley I.J., et al. The prospective course of postconcussion syndrome: the role of mild traumatic brain injury. Neuropsychology 2011, 25(4):454-465. 10.1037/a0022580.
142. Mease P.J. Certolizumab pegol in the treatment of rheumatoid arthritis: a comprehensive review of its clinical efficacy and safety. Rheumatology 2011, 50(2):261-270. 10.1093/rheumatology/keq285.
143. Mendozzi L., Tronci F., Garegnani M., Pugnetti L. Sleep disturbance and fatigue in mild relapsing remitting multiple sclerosis patients on chronic immunomodulant therapy: an actigraphic study. Mult. Scler. 2010, 16(2):238-247. 10.1177/1352458509354551.
144. Meng Q., Niu Y., Niu X., Roubin R.H., Hanrahan J.R. Ethnobotany, phytochemistry and pharmacology of the genus Caragana used in traditional Chinese medicine. J. Ethnopharmacol. 2009, 124(3):350-368. 10.1016/j.jep.2009.04.048.
145. Menza M., Dobkin R.D., Marin H., Mark M.H., Gara M., Bienfait K., et al. The role of inflammatory cytokines in cognition and other non-motor symptoms of Parkinson's disease. Psychosomatics 2010, 51(6):474-479. 10.1176/appi.psy.51.6.474.
146. Messé A., Caplain S., Pélégrini-Issac M., Blancho S., Lévy R., Aghakhani N., et al. Specific and evolving resting-state network alterations in post-concussion syndrome following mild traumatic brain injury. PLoS One 2013, 8(6):e65470. 10.1371/journal.pone.0065470.
147. Miaskowski C., Aouizerat B.E. Biomarkers: symptoms, survivorship, and quality of life. Semin. Oncol. Nurs. 2012, 28(2):129-138. 10.1016/j.soncn.2012.03.008.
148. Michetti F., Corvino V., Geloso M.C., Lattanzi W., Bernardini C., Serpero L., Gazzolo D. The S100B protein in biological fluids: more than a lifelong biomarker of brain distress. J. Neurochem. 2012, 120(5):644-659. 10.1111/j.1471-4159.2011.07612.x.
149. Miller A.A., Spencer S.J. Obesity and neuroinflammation: a pathway to cognitive impairment. Brain Behav. Immun. 2014, 42:10-21.
150. Miller R.J., Jung H., Bhangoo S.K., White F.A. Cytokine and chemokine regulation of sensory neuron function. Sensory Nerves 2009, vol. 194. Springer, Berlin, Heidelberg, pp. 417-499. http://dx.doi.org/10.1007/978-3-540-79090-7_12.
151. Mina F., Comim C.M., Dominguini D., Cassol-Jr O.J., Dall Igna D.M., Ferreira G.K., et al. Il1-β involvement in cognitive impairment after sepsis. Mol. Neurobiol. 2014, 49(2):1069-1076. 10.1007/s12035-013-8581-9.
152. Morris G., Maes M. A neuro-immune model of Myalgic Encephalomyelitis/Chronic fatigue syndrome. Metab. Brain Dis. 2013, 28(4):523-540. 10.1007/s11011-012-9324-8.
153. Morris G.P., Clark I.A., Zinn R., Vissel B. Microglia: a new frontier for synaptic plasticity, learning and memory, and neurodegenerative disease research. Neurobiol. Learn. Mem. 2013, 105 (C):40-53. 10.1016/j.nlm.2013.07.002.
154. Müller N. The role of anti-inflammatory treatment in psychiatric disorders. Psychiatr. Danub. 2013, 25(3):292-298.
155. Na N.A. Definition of mild traumatic brain injury. J. Head Trauma Rehabil. 1993, 8(3):86-87. 10.1097/00001199-199309000-00010.
156. Nadelson M.R., Sanders R.D., Avidan M.S. Perioperative cognitive trajectory in adults. Br. J. Anaesth. 2014, 112(3):440-451. 10.1093/bja/aet420.
157. Nemunaitis J., Vukelja S.J., Richards D., Cunningham C., Senzer N., Nugent J., et al. Phase I trial of PT-100 (PT-100), a cytokine-inducing small molecule, following chemotherapy for solid tumor malignancy. Cancer Invest. 2006, 24(6):553-561. 10.1080/07357900600894732.
158. Nijs J., Nees A., Paul L., De Kooning M., Ickmans K., Meeus M., Van Oosterwijck J. Altered immune response to exercise in patients with chronic fatigue syndrome/myalgic encephalomyelitis: a systematic literature review. Exerc. Immunol. Rev. 2014, 20:94-116.
159. Noble J.M., Manly J.J., Schupf N., Tang M.X., Mayeux R., Luchsinger J.A. Association of C-reactive protein with cognitive impairment. Arch. Neurol. 2010, 67(1):87-92. 10.1001/archneurol.2009.308.
160. Osborne L.M., Monk C. Perinatal depression-the fourth inflammatory morbidity of pregnancy? Theory and literature review. Psychoneuroendocrinology 2013, 38(10):1929-1952. 10.1016/j.psyneuen.2013.03.019.
161. Pace T.W.W., Heim C.M. A short review on the psychoneuroimmunology of posttraumatic stress disorder: from risk factors to medical comorbidities. Brain Behav. Immun. 2011, 25(1):6-13. 10.1016/j.bbi.2010.10.003.
162. Park J., Zhang J., Qiu J., Zhu X., Degterev A., Lo E.H., Whalen M.J. Combination therapy targeting Akt and mammalian target of rapamycin improves functional outcome after controlled cortical impact in mice. J. Cereb. Blood Flow Metab. 2012, 32(2):330-340. 10.1038/jcbfm.2011.131.
163. Pelinka L.E., Szalay L., Jafarmadar M., Schmidhammer R., Redl H., Bahrami S. Circulating S100B is increased after bilateral femur fracture without brain injury in the rat. Br. J. Anaesth. 2003, 91(4):595-597.
164. Pelinka L.E., Toegel E., Mauritz W., Redl H. Serum S 100 B: a marker of brain damage in traumatic brain injury with and without multiple trauma. Shock 2003, 19(3):195-200.
165. Peng L., Xu L., Ouyang W. Role of peripheral inflammatory markers in postoperative cognitive dysfunction (POCD): a meta-analysis. PLoS One 2013, 8(11):e79624. 10.1371/journal.pone.0079624.
166. Pertosa G., Grandaliano G., Gesualdo L., Schena F.P. Clinical relevance of cytokine production in hemodialysis. Kidney Int. Suppl. 2000, 76:S104-11.
167. Pesce M., Speranza L., Franceschelli S., Ialenti V., Iezzi I., Patruno A., et al. Positive correlation between serum interleukin-1β and state anger in rugby athletes. Aggressive Behav. 2013, 39(2):141-148. 10.1002/ab.21457.
168. Plosker G.L. Interferon-β-1b: a review of its use in multiple sclerosis. CNS Drugs 2011, 25(1):67-88. 10.2165/11206430-000000000-00000.
169. Pollmächer T., Mullington J., Korth C., Hinze-Selch D. Influence of host defense activation on sleep in humans. Adv. Neuroimmunol. 1995, 5(2):155-169.
170. Poole L., Dickens C., Steptoe A. The puzzle of depression and acute coronary syndrome: reviewing the role of acute inflammation. J. Psychosom. Res. 2011, 71(2):61-68. 10.1016/j.jpsychores.2010.12.009.
171. Poon D.C.-H., Ho Y.-S., Chiu K., Chang R.C.-C. Cytokines: how important are they in mediating sickness?. Neurosci. Biobehav. Rev. 2013, 37(1):1-10. 10.1016/j.neubiorev.2012.11.001.
172. Poon D.C.-H., Ho Y.-S., Chiu K., Chang R.C.-C. Cytokines: how important are they in mediating sickness?. Neurosci. Biobehav. Rev. 2013, 37(1):1-10. 10.1016/j.neubiorev.2012.11.001.
173. Prather A.A., Rabinovitz M., Pollock B.G., Lotrich F.E. Cytokine-induced depression during IFN-alpha treatment: the role of IL-6 and sleep quality. Brain Behav. Immun. 2009, 23(8):1109-1116. 10.1016/j.bbi.2009.07.001.
174. Préau M., Marcellin F., Spire B., Ravaux I., Dellamonica P., Blanc D., Carrieri M.P. Impaired anger control as an underappreciated side effect of treatments for chronic HCV infection in HIV-HCV coinfected patients. J. Clin. Gastroenterol. 2008, 42(1):92-96. 10.1097/01.mcg.0000225645.75651.b8.
175. Prodan C.I., Vincent A.S., Dale G.L. Coated-platelet levels are persistently elevated in patients with mild traumatic brain injury. J. Head Trauma Rehabil. 2013, 1. 10.1097/HTR.0000000000000010.
176. Raison C.L., Demetrashvili M., Capuron L., Miller A.H. Neuropsychiatric adverse effects of interferon-alpha: recognition and management. CNS Drugs 2005, 19(2):105-123.
177. Raison C.L., Rye D.B., Woolwine B.J., Vogt G.J., Bautista B.M., Spivey J.R., Miller A.H. Chronic interferon-alpha administration disrupts sleep continuity and depth in patients with hepatitis C: association with fatigue, motor slowing, and increased evening cortisol. Biol. Psychiatry 2010, 68(10):942-949. 10.1016/j.biopsych.2010.04.019.
178. Rasmussen L.S., Christiansen M., Rasmussen H., Kristensen P.A., Moller J.T. Do blood concentrations of neurone specific enolase and S-100 beta protein reflect cognitive dysfunction after abdominal surgery? ISPOCD Group. Br. J. Anaesth. 2000, 84(2):242-244.
179. Rasmussen L.S., Christiansen M., Eliasen K., Sander-Jensen K., Moller J.T. Biochemical markers for brain damage after cardiac surgery - time profile and correlation with cognitive dysfunction. Acta Anaesthesiol. Scand. 2002, 46(5):547-551.
180. Razeghi E., Sahraian M.A., Heidari R., Bagherzadeh M. Association of inflammatory biomarkers with sleep disorders in hemodialysis patients. Acta Neurol. Belg. 2012, 112(1):45-49. 10.1007/s13760-012-0003-7.
181. Redell J.B., Moore A.N., Grill R.J., Johnson D., Zhao J., Liu Y., Dash P.K. Analysis of functional pathways altered after mild traumatic brain injury. J. Neurotrauma 2013, 30(9):752-764. 10.1089/neu.2012.2437.
182. Reichmann F., Painsipp E., Holzer P. Environmental enrichment and gut inflammation modify stress-induced c-Fos expression in the mouse corticolimbic system. PLoS One 2013, 8(1):e54811. 10.1371/journal.pone.0054811.
183. Robson P. Elucidating the unexplained underperformance syndrome in endurance athletes: the interleukin-6 hypothesis. Sports Med. 2003, 33(10):771-781.
184. Roxburgh C.S.D., McMillan D.C. Cancer and systemic inflammation: treat the tumour and treat the host. Br. J. Cancer 2014, 110(6):1409-1412. 10.1038/bjc.2014.90.
185. Rozen T.D. New daily persistent headache. Curr. Opin. Neurol. 2011, 24(3):211-216. 10.1097/WCO.0b013e328345c5ad.
186. Rubio C., Paz C. Indomethacin reverts sleep disorders produced by ozone exposure in rats. Toxicology 2003, 191(2-3):89-96.
187. Russo S., Kema I.P., Haagsma E.B., Boon J.C., Willemse P.H.B., den Boer J.A., et al. Irritability rather than depression during interferon treatment is linked to increased tryptophan catabolism. Psychosom. Med. 2005, 67(5):773-777. 10.1097/01.psy.0000171193.28044.d8.
188. Saligan L.N., Kim H.S. A systematic review of the association between immunogenomic markers and cancer-related fatigue. Brain Behav. Immun. 2012, 26(6):830-848. 10.1016/j.bbi.2012.05.004.
189. Schmidt E.D., Janszen A.W., Wouterlood F.G., Tilders F.J. Interleukin-1-induced long-lasting changes in hypothalamic corticotropin-releasing hormone (CRH)-neurons and hyperresponsiveness of the hypothalamus-pituitary-adrenal axis. J. Neurosci. 1995, 15(11):7417-7426.
190. Schmidt E.D., Aguilera G., Binnekade R., Tilders F.J.H. Single administration of interleukin-1 increased corticotropin releasing hormone and corticotropin releasing hormone-receptor mRNA in the hypothalamic paraventricular nucleus which paralleled long-lasting (weeks) sensitization to emotional stressors. Neuroscience 2003, 116(1):275-283.
191. Schneiderman A.I., Braver E.R., Kang H.K. Understanding sequelae of injury mechanisms and mild traumatic brain injury incurred during the conflicts in Iraq and Afghanistan: persistent postconcussive symptoms and posttraumatic stress disorder. Am. J. Epidemiol. 2008, 167(12):1446-1452. 10.1093/aje/kwn068.
192. Schuff N., Zhang Y., Zhan W., Lenoci M., Ching C., Boreta L., et al. Patterns of altered cortical perfusion and diminished subcortical integrity in posttraumatic stress disorder: an MRI study. NeuroImage 2011, 54:S62-S68. 10.1016/j.neuroimage.2010.05.024.
193. Selianina N.V., Karakulova I.V., Eroshina O.A. The role of neuromediators and cytokines in the pathogenesis of acute traumatic brain injury. Zhurnal Voprosy Neĭrokhirurgii Imeni N. N. Burdenko 2013, 77(6):22-26. discussion 27.
194. Semmler A., Widmann C.N., Okulla T., Urbach H., Kaiser M., Widman G., et al. Persistent cognitive impairment, hippocampal atrophy and EEG changes in sepsis survivors. J. Neurol. Neurosurg. Psychiatry 2013, 84(1):62-69. 10.1136/jnnp-2012-302883.
195. Serafini G., Pompili M., Elena Seretti M., Stefani H., Palermo M., Coryell W., Girardi P. The role of inflammatory cytokines in suicidal behavior: a systematic review. Eur. Neuropsychopharmacol. 2013, 23(12):1672-1686. 10.1016/j.euroneuro.2013.06.002.
196. Shenton M.E., Hamoda H.M., Schneiderman J.S., Bouix S., Pasternak O., Rathi Y., et al. A review of magnetic resonance imaging and diffusion tensor imaging findings in mild traumatic brain injury. Brain Imag. Behav. 2012, 6(2):137-192. 10.1007/s11682-012-9156-5.
197. Shiohira S., Yoshida T., Sugiura H., Yoshida S., Mitobe M., Shimada K., et al. Effect of the antiplatelet agent cilostazol on endovascular inflammatory biochemical parameters and the clinical symptoms of peripheral artery disease and restless legs syndrome in hemodialysis patients. Clin. Exp. Nephrol. 2011, 15(6):893-899. 10.1007/s10157-011-0485-2.
198. Shultz S.R., Bao F., Omana V., Chiu C., Brown A., Cain D.P. Repeated mild lateral fluid percussion brain injury in the rat causes cumulative long-term behavioral impairments, neuroinflammation, and cortical loss in an animal model of repeated concussion. J. Neurotrauma 2012, 29(2):281-294. 10.1089/neu.2011.2123.
199. Shultz S.R., Bao F., Weaver L.C., Cain D.P., Brown A. Treatment with an anti-CD11d integrin antibody reduces neuroinflammation and improves outcome in a rat model of repeated concussion. J. Neuroinflammation 2013, 10(1):26. 10.1186/1742-2094-10-26.
200. Silverberg N.D., Iverson G.L. Is rest after concussion "the best medicine?". J. Head Trauma Rehabil. 2013, 28(4):250-259. 10.1097/HTR.0b013e31825ad658.
201. Simpson E.E.A., Hodkinson C.F., Maylor E.A., McCormack J.M., Rae G., Strain S., et al. Intracellular cytokine production and cognition in healthy older adults. Psychoneuroendocrinology 2013, 38(10):2196-2208. 10.1016/j.psyneuen.2013.04.007.
202. Sobbi S., van den Boogaard M. Inflammation biomarkers and delirium in critically ill patients: new insights?. Crit. Care 2014, 18(3):153. 10.1186/cc13930.
203. Sockalingam S., Abbey S.E., Alosaimi F., Novak M. A review of sleep disturbance in hepatitis C. J. Clin. Gastroenterol. 2010, 44(1):38-45. 10.1097/MCG.0b013e3181b314ea.
204. Späth-Schwalbe E., Hansen K., Schmidt F., Schrezenmeier H., Marshall L., Burger K., et al. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men. J. Clin. Endocrinol. Metab. 1998, 83(5):1573-1579. 10.1210/jcem.83.5.4795.
205. Spennati A., Pariante C.M. Withdrawing interferon-α from psychiatric patients: clinical care or unjustifiable stigma?. Psychol. Med. 2013, 43(6):1127-1132. 10.1017/S0033291712001808.
206. Stack R.J., Sahni M., Mallen C.D., Raza K. Symptom complexes at the earliest phases of rheumatoid arthritis: a synthesis of the qualitative literature. Arthritis Care Res. 2013, 65(12):1916-1926. 10.1002/acr.22097.
207. Sternberg E.M. Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens. Nat. Rev. Immunol. 2006, 6(4):318-328. 10.1038/nri1810.
208. Su S.-H., Xu W., Li M., Zhang L., Wu Y.-F., Yu F., Hai J. Elevated C-reactive protein levels may be a predictor of persistent unfavourable symptoms in patients with mild traumatic brain injury: a preliminary study. Brain Behav. Immun. 2014, 38:111-117. 10.1016/j.bbi.2014.01.009.
209. Suarez E.C., Lewis J.G., Kuhn C. The relation of aggression, hostility, and anger to lipopolysaccharide-stimulated tumor necrosis factor (TNF)-alpha by blood monocytes from normal men. Brain Behav. Immun. 2002, 16(6):675-684.
210. Suarez E.C., Lewis J.G., Krishnan R.R., Young K.H. Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology 2004, 29(9):1119-1128. 10.1016/j.psyneuen.2004.01.002.
211. Swanepoel T., Harvey B.H., Harden L.M., Laburn H.P., Mitchell D. Dissociation between learning and memory impairment and other sickness behaviours during simulated Mycoplasma infection in rats. Brain Behav. Immun. 2011, 25(8):1607-1616. 10.1016/j.bbi.2011.05.008.
212. Taraz M., Khatami M.-R., Hajiseyedjavadi M., Farrokhian A., Amini M., Khalili H., et al. Association between antiinflammatory cytokine, IL-10, and sleep quality in patients on maintenance hemodialysis. Hemodial. Int. 2013, 17(3):382-390. 10.1111/hdi.12035.
213. Terrando N., Monaco C., Ma D., Foxwell B.M.J., Feldmann M., Maze M. Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline. Proc. Natl. Acad. Sci. USA 2010, 107(47):20518-20522. 10.1073/pnas.1014557107.
214. Theadom A., Mahon S., Barker-Collo S., McPherson K., Rush E., Vandal A.C., Feigin V.L. Enzogenol for cognitive functioning in traumatic brain injury: a pilot placebo-controlled RCT. Eur. J. Neurol. 2013, 20(8):1135-1144. 10.1111/ene.12099.
215. Topolovec-Vranic J., Pollmann-Mudryj M.-A., Ouchterlony D., Klein D., Spence J., Romaschin A., et al. The value of serum biomarkers in prediction models of outcome after mild traumatic brain injury. J. Trauma 2011, 71(5 Suppl. 1):S478-86. 10.1097/TA.0b013e318232fa70.
216. Valkanova V., Ebmeier K.P., Allan C.L. CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies. J. Affect. Disord. 2013, 150(3):736-744. 10.1016/j.jad.2013.06.004.
217. van der Kolk B.A., Pelcovitz D., Roth S., Mandel F.S., McFarlane A., Herman J.L. Dissociation, somatization, and affect dysregulation: the complexity of adaptation of trauma. Am. J. Psychiatry 1996, 153(7 Suppl):83-93.
218. Vezali E., Aghemo A., Colombo M. A review of the treatment of chronic hepatitis C virus infection in cirrhosis. Clin. Ther. 2010, 32(13):2117-2138. 10.1016/S0149-2918(11)00022-1.
219. Vlachoyiannopoulos P.G., Tsifetaki N., Dimitriou I., Galaris D., Papiris S.A., Moutsopoulos H.M. Safety and efficacy of recombinant gamma interferon in the treatment of systemic sclerosis. Ann. Rheum. Dis. 1996, 55(10):761-768.
220. von Känel R., Mausbach B.T., Ancoli-Israel S., Dimsdale J.E., Mills P.J., Patterson T.L., et al. Sleep in spousal Alzheimer caregivers: a longitudinal study with a focus on the effects of major patient transitions on sleep. Sleep 2012, 35(2):247-255. 10.5665/sleep.1632.
221. Walker F.R. A critical review of the mechanism of action for the selective serotonin reuptake inhibitors: do these drugs possess anti-inflammatory properties and how relevant is this in the treatment of depression?. Neuropharmacology 2013, 67:304-317. 10.1016/j.neuropharm.2012.10.002.
222. Walsh J.T., Watson N., Kipnis J. T cells in the central nervous system: messengers of destruction or purveyors of protection?. Immunology 2014, 141(3):340-344. 10.1111/imm.12187.
223. Wärnberg J., Cunningham K., Romeo J., Marcos A. Physical activity, exercise and low-grade systemic inflammation. Proc. Nutr. Soc. 2010, 69(3):400-406. 10.1017/S0029665110001928.
224. Weinstein A.A., Deuster P.A., Francis J.L., Bonsall R.W., Tracy R.P., Kop W.J. Neurohormonal and inflammatory hyper-responsiveness to acute mental stress in depression. Biol. Psychol. 2010, 84(2):228-234. 10.1016/j.biopsycho.2010.01.016.
225. Wells G., Li T., Tugwell P. Investigation into the impact of abatacept on sleep quality in patients with rheumatoid arthritis, and the validity of the MOS-Sleep questionnaire Sleep Disturbance Scale. Ann. Rheum. Dis. 2010, 69(10):1768-1773. 10.1136/ard.2009.119727.
226. Wieczorek S., Gencik M., Rujescu D., Tonn P., Giegling I., Epplen J.T., Dahmen N. TNFA promoter polymorphisms and narcolepsy. Tissue Antigens 2003, 61(6):437-442.
227. Wieczorek S., Dahmen N., Kasten M., Epplen J.T., Gencik M. A rare form of narcolepsy (HLA-DR2-) shows possible association with (functionally relevant) alpha-interferon gene polymorphisms. Psychiatr. Genet. 2004, 14(1):47-51.
228. Wisløff F., Hjorth M., Kaasa S., Westin J. Effect of interferon on the health-related quality of life of multiple myeloma patients: results of a Nordic randomized trial comparing melphalan-prednisone to melphalan-prednisone + alpha-interferon. The Nordic Myeloma Study Group. Br. J. Haematol. 1996, 94(2):324-332.
229. Wiwanitkit V. Headache and malaria: a brief review. Acta Neurol. Taiwan. 2009, 18(1):56-59.
230. Wood L.J., Weymann K. Inflammation and neural signaling: etiologic mechanisms of the cancer treatment-related symptom cluster. Curr. Opin. Support. Palliat. Care 2013, 7(1):54-59. 10.1097/SPC.0b013e32835dabe3.
231. Woodruff R.T., Schorpp K.M., Lawrenczyk A.J., Chakraborty T., Kusnecov A.W. Effects of acute and repeated administration of Staphylococcal enterotoxin A on Morris water maze learning, corticosterone and hippocampal IL-1β and TNF-α. Brain Behav. Immun. 2011, 25(5):938-946. 10.1016/j.bbi.2010.10.005.
232. World Health Organization (WHO). (2009). The ICD-10 classification of mental and behavioural disorders: Clinical description and diagnostic gUidelines [WHO Web site].
233. Yang J.-Y., Huang J.-W., Chiang C.-K., Pan C.-C., Wu K.-D., Tsai T.-J., Chen W.-Y. Higher plasma interleukin-18 levels associated with poor quality of sleep in peritoneal dialysis patients. Nephrol. Dial. Transplant. 2007, 22(12):3606-3609. 10.1093/ndt/gfm231.
234. Yang S.H., Gustafson J., Gangidine M., Stepien D., Schuster R., Pritts T.A., et al. A murine model of mild traumatic brain injury exhibiting cognitive and motor deficits. J. Surg. Res. 2013, 184(2):981-988. 10.1016/j.jss.2013.03.075.
235. Yi P.-L., Tsai C.-H., Lu M.-K., Liu H.-J., Chen Y.-C., Chang F.-C. Interleukin-1beta mediates sleep alteration in rats with rotenone-induced parkinsonism. Sleep 2007, 30(4):413-425.
236. Zargar-Shoshtari K., Hill A.G. Postoperative fatigue: a review. World J. Surg. 2009, 33(4):738-745. 10.1007/s00268-008-9906-0.
237. Zhu X., Park J., Golinski J., Qiu J., Khuman J., Lee C.C.H., et al. Role of Akt and mammalian target of rapamycin in functional outcome after concussive brain injury in mice. J. Cereb. Blood Flow Metab. 2014, 34(9):1531-1539. 10.1038/jcbfm.2014.113.